THE HEADLINES ARE FRIGHTENING: “Hair-straightening chemical products linked to increased uterine cancer risk in a new study,” blares CNN. NBC News offers this: “Chemical hair straighteners linked to [a] higher risk of uterine cancer for Black women, study shows.”
Chemo. A word that encompasses equal portions of dread, hope and despair. Many view it as a last ditch deal, a long, lingering chemical experiment which few survive or profit from
he stark disparity in the diagnosis and treatment of Acute Lymphoblastic Leukaemia (ALL) between high-income countries (HICs) and low- and middle-income countries (LMICs) highlights a critical issue in global healthcare equity.